The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis
J Clin Gastroenterol
October 2015
https://www.academia.edu/28700218/Initial_Findings_of_an_Open_Label_Trial_of_Low_Dose_Naltrexone_for_Symptomatic_Mesenteric_Panniculitis
Effects of low-dose naltrexone on feed intake, growth, endocrine and immune parameters in the recently-weaned pig
Masters Thesis, University of Tennessee, Knoxville
December 2015
https://www.semanticscholar.org/paper/Effects-of-low-dose-naltrexone-on-feed-intake%2C-and-Carter/c487fc0f07daaed24e0ba8693e18d37ed369303b
Opioid growth factor and low dose naltrexone impair central nervous system infiltration by CD4+T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis
Exp Biol Med (Maywood)
January 2016
http://www.ncbi.nlm.nih.gov/pubmed/26202376
Functional modulation on macrophage by low dose naltrexone (LDN)
Int Immunopharmacol
October 2016
https://www.ncbi.nlm.nih.gov/pubmed/27561742
Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone
Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis
Exp Biol Med (Maywood)
November 2009
https://pubmed.ncbi.nlm.nih.gov/19855075/
Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment
BMJ Case Reports
January 2018
https://casereports.bmj.com/content/2018/bcr-2017-221405
The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris; a randomized controlled clinical trial
J Dermatolog Treat
08 June 2020
https://pubmed.ncbi.nlm.nih.gov/32449418/
Bernard Bihari, MD: Low-Dose Naltrexone for normalizing immune system function
Altern Ther Health Med
05 November 2013
http://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf